Investors

Webcast
Ocular Therapeutix, Inc. at the JMP Securities Life Sciences Conference
Wednesday, June 16, 2021 12:00 PM EDT
Webcast
Ocular Therapeutix, Inc. at the Jefferies Virtual Healthcare Conference
Tuesday, June 01, 2021 4:00 PM EDT

Corporate Profile

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
(Common Stock)

Data Provided by Refinitiv. Minimum 15 minutes delayed.